| Date |
Name |
Supervisors |
Title |
| 2011-02-04 |
Anna K. Krabbe Lugnér
|
Prof dr MJ Postma |
Cost-effectiveness of controlling infectious diseases from a public health perspective
|
| 2010-04-16 |
Mark Connolly
|
Prof dr MJ Postma
Prof dr W Ledger
|
The Economics of assisted reproduction. Costs and consequences of fertility treatments. |
| 2010-01-11 |
Marian K. Bakker
|
prof dr CHCM Buijs
Prof dr LTW de Jong van den berg |
The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy. |
| 2010-01-08 |
Robin de Vries
|
Prof dr MJ Postma
Prof dr LTW de Jong van den berg |
Health-economics of interventions aimed at infectious diseases: dynamic modeling inevitable for reliable decision making. |
| 2009-06-12 |
Cornelis Boersma
|
Prof dr MJ Postma
Prof dr LTW de Jong van den berg
Prof dr PE de Jong |
Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings. |
| 2009-05-11 |
Gijs Hubben
|
Prof dr MJ Postma |
Cost-effectiveness of infectious disease interventions : combining economic modelling and web technology to support decision making. |
| 2009-03-20 |
Fokaline Vroom
|
Prof dr LTW de Jong-van den Berg
Prof dr JRBJ Brouwers
Prof dr MAFJ van de Laar |
Drug use in pregnancy. Exploring the field of DMARDs in pregnancy. |
| 2006-12-08 |
Willemijn Meijer
|
prof dr LTW de Jong-van den Berg
prof dr JRBJ Brouwers |
Drug safety in pregnancy. Studying and communicating teratogenic risks. |
| 2006-10-02 |
Adrianne Faber
|
prof dr LTW de Jong-van den Berg |
Stimulant treatment in children: a Dutch perspective. |
| 2006-09-15 |
Jarir Atthobari
|
prof dr LTW de Jong-van den Berg
prof dr PE de Jong |
Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects. |
| 2006-06-30 |
Rogier Klok
|
Prof dr JRBJ Brouwers
Prof dr MJ Postma |
Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection. |
| 2004-12-17 |
Ada Stuurman-Bieze
|
Prof dr LTW de Jong-van den Berg
Dr ThFJ Tromp |
Interventions on the principle of Pulmonary Medication Profiles. |
| 2004-11-19 |
Andrea Tramarin
|
Prof dr JRBJ Brouwers
Dr MJ Postma |
The changing economic burden of HIV/AIDS in Italy. |
| 2004-01-09 |
Jasper Bos
|
Prof dr LTW de Jong-van den Berg
Dr MJ Postma |
Pharmacoeconomics in infectious disease. The evaluation of prevention programmes. |
| 2003-11-18 |
Kees van Grootheest
|
Prof dr LTW de Jong-van den Berg
Dr EP van Puijenbroek |
Improving Pharmacovigilance and the Role of the Pharmacist. |
| 2003-10-03 |
Eric Schirm
|
Prof dr LTW de Jong-van den Berg
Dr H Tobi |
Drug Exposure from conception till adulthood. |
| 2003-10-03 |
Claudia Rijcken
|
Prof dr LTW de Jong-van den Berg |
Pharmacy Data as a Tool for assessing Antypsychotic Drug Use. |
| 2003-01-31 |
Taco Monster
|
Prof dr LTW de Jong-van den Berg
Prof dr PE de Jong
Dr H Tobi |
Assessing drug influences on urinary albumin excretion. |
| 2002-06-07 |
Karen van Dijk
|
Prof dr LTW de Jong-van den Berg
Prof JRBJ Brouwers |
pharmacotherapy in frail elderly. |
| 2001-11-10 |
Nicolien Wieringa
|
Prof dr R Vos
Prof dr PA de Graeff |
marketing Clinical Research and Medical Practice: the case of cardiovascular drugs. |
| 2001-05-04 |
Roel Fijn
|
Prof dr LTW de Jong-van den Berg
Prof dr JRBJ Brouwers |
Managing Rational Pharmacotherapy in Hospitals: what about drug formularies and pharmacotherapeutic guidelines?. |
| 2001-01-19 |
Marc Weeber
|
Prof dr R Vos
Prof dr LTW de Jong-van den Berg |
Literature-based Discovery in Biomedicine. |
| 2000-06-21 |
Janette Reefhuis
|
Prof dr CHCM Buys
Prof dr LTW de Jong-van den Berg |
The Use of Birth Defect Registries for Etiological Research. |
| 1999-01-28 |
Foppe van Mil
|
Prof dr ThFJ Tromp
Prof dr LTW de Jong-van den Berg
Prof dr J McElnay |
Pharmaceutical care, the future of pharmacy. |
| 1998-10-16 |
Corinne de Vries
|
Prof dr LTW de Jong-van den Berg
Prof dr ThFJ Tromp |
Collaboration in healthcare, the tango to drug safety. |
| 2001-06-18 |
Hermien EK de Walle
|
Prof dr CHCM Buys
Prof dr LTW de Jong-van den Berg
|
Awareness and use of folic acid in the Netherlands: from science to practice.
|
| 1998 |
Floor Rikken
|
Prof dr R Vos
Prof dr DKF Meijer
Prof dr W van Rossum |
Adverse Drug Reactions in a Different Context; a scientometric approach towards adverse drug reactions as a trigger for the development of new drugs. |
| 1995 |
Anke van Trigt
|
Prof dr ThFJ Tromp
Prof dr MNG Dukes
Prof dr FM Haaijer-Ruskamp
Dr LTW de Jong-van den Berg |
Making News about Medicines. |
| 1995 |
Miriam Sturkenboom
|
Prof dr H Wesseling
Prof dr DKF Meijer
Dr LTW de Jong-van den Berg |
A Field-oriented Postmarketing Surveillance Study on the Teratogen Acitretin. |
| 1992 |
Lolkje de Jong-van den Berg
|
Prof dr MNG Dukes
Prof dr H Wesseling
Dr FM Haaijer-Ruskamp |
Drug Utilization Studies in Pregnancy; what can they contribute to safety assessment?. |
| 1989 |
Rein Vos
|
Prof dr DKF Meijer
Prof dr AJ Dunning
Prof dr TAF Kuipers
Dr HWHJ Bodewitz |
Drugs Looking for Diseases; a descriptive model for the process of innovative drug research with special reference to the development of beta blockers and the calcium antagonists. |
